Monoclonal Antibodies (mAbs) targeting the CD47 protein are currently the most advanced and widely studied class of agents in the CD47 Targeting Therapeutics domain. Their established history in oncology, high specificity for the target protein, and potential for potent macrophage activation make them the preferred modality for initial drug development.
These antibodies function primarily by...
จองคิวบริการ
NR tours
Youplay
NR shop
NR jobs
facebook th
thai 
English
French
Spanish
Portuguese
Italiano
Romaian
Portuguese (Brazil)
china